Gene Therapy for POTS

Overview: What is POTS?

Postural Orthostatic Tachycardia Syndrome (POTS) is a chronic form of dysautonomia characterized by an excessive increase in heart rate (≥30 bpm in adults, ≥40 bpm in adolescents) upon assuming an upright posture, without orthostatic hypotension. It leads to symptoms of cerebral hypoperfusion and sympathetic overactivation. The condition is heterogeneous, with contributing mechanisms including neuropathic impairment, hyperadrenergic states, autoimmunity (e.g., autoantibodies targeting adrenergic and muscarinic receptors), small-fiber neuropathy, and impaired venous return.

Basic Information

  • Prevalence: 0.2–1% of the population; predominantly affects females (≈5:1 female-to-male ratio), typically aged 15–50.
  • Common precipitants: viral infections, surgery, pregnancy, concussion, or vaccination in susceptible individuals.
  • Pathophysiological subtypes: neuropathic POTS, hyperadrenergic POTS, autoimmune POTS, and overlap with mast cell activation syndrome or Ehlers-Danlos syndrome.
  • Diagnostic standard: Head-up tilt-table testing or active stand test confirming heart-rate criteria plus symptom reproduction. Additional testing may include plasma catecholamines, skin biopsy for small-fiber neuropathy, and autoantibody panels.
  • Current therapeutic paradigm: symptomatic only; no disease-modifying or gene-targeted therapies are approved as of 2026.

Personal Inspiration

This entire research program is profoundly inspired by a close friend who is severely affected by POTS. Their daily experience of debilitating orthostatic intolerance, chronic fatigue, neuropathic pain, and autonomic instability has provided unwavering motivation to pursue gene therapy solutions capable of addressing root genetic and autoimmune mechanisms rather than offering only palliative symptom relief. The 5–10 year roadmap below is dedicated to their struggle and to all patients awaiting curative advances.

Questions or Collaboration?

Have research questions, funding opportunities, or collaboration ideas? I'd love to hear from you.